IPACK Block for Postoperative Pain After ACL Surgery
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after surgery and at 1 day after surgery * if participants who receive the IPACK block prior to ACL reconstruction require less short-term opioid use immediately after surgery and up to one week after surgery. Participants will be randomized 1:1 to 1 of 2 groups: Use of IPACK block during ACL reconstruction vs. placebo (a placebo is a look-alike substance that contains no active drug). Neither the participant nor the investigator will know which group the participants has been assigned to. Researchers will compare self-reported pain scores and short-term opioid use of all study participants.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are a chronic opioid user, you cannot participate in the trial.
What data supports the effectiveness of the IPACK treatment for reducing postoperative pain after ACL surgery?
Is the IPACK block safe for use in humans?
How does the IPACK block treatment differ from other treatments for postoperative pain after ACL surgery?
The IPACK block is a novel technique that targets pain in the back of the knee by injecting anesthetic between the popliteal artery and the knee capsule, providing effective pain relief without causing muscle weakness. This approach is unique because it can reduce the need for opioids and enhance the effects of other nerve blocks used in knee surgeries.148910
Eligibility Criteria
This trial is for patients 16 or older who are undergoing ACL reconstruction at Loyola University Medical Center and can make their own medical decisions. It's not for those with chronic opioid use, using cadaver grafts, allergic to local anesthetics, or with past surgery/infections in the knee.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ACL reconstruction surgery with either an IPACK block or placebo
Immediate Post-operative Monitoring
Pain scores and opioid consumption are monitored in the PACU immediately after surgery
Follow-up
Participants are monitored for pain scores and opioid use up to one week post-operatively
Treatment Details
Interventions
- IPACK
- PLACEBO
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loyola University
Lead Sponsor